It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
Federal officials have approved new pain medication Journavx, designed to offer short-term pain relief without the addiction and overdose risks associated with opioids like Vicodin and OxyContin. The ...
"There's different kinds of pain, just like we know in humans," explains Dr. Jerry Klein, a chief veterinary officer at the American Kennel Club. "There's acute pain and there's chronic pain; there's ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...